BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
BioRestorative Therapies, Inc.
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026
$1.60+0.06 (+3.90%)
Close on Oct 19, 2026
- Market cap
- $28.36M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns BioRestorative Therapies's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Dale Broadrick | 926,376 | – | 13D (active) amendment | Feb 8, 2024 |
| Alfred Sollami | 692,418 | 9.90% | 13G (passive) amendment | Sep 30, 2024 |
| Louis Posner | 2,699,470 | 9.90% | 13G (passive) amendment | Mar 31, 2026 |
| Alstodt Lance | 1,236,809 | 15.50% | 13D (active) amendment | Feb 14, 2025 |
| Silva, Francisco | 1,196,819 | 15.10% | 13D (active) amendment | Feb 14, 2025 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Francisco Silva | VP of Research and Development, Director | 183,520 | 0.72% | Oct 20, 2025 |
| Lance Alstodt | President, CEO, COB, Director, 10% owner | 187,497 | 0.74% | Oct 20, 2025 |
| Robert Eugene Kristal | Chief Financial Officer | 7,994 | 0.03% | Feb 19, 2025 |
| Esha Randhawa | Director | – | – | Jul 30, 2026 |
| Steven Collier Brown | Director | – | – | Jul 24, 2026 |
| Jatinder Dhaliwal | Director | – | – | Jun 18, 2026 |
| Mika Grasso | Director | – | – | Jun 18, 2026 |
| Katharyn Field | Director | – | – | Jun 17, 2026 |
| Nickolay V. Kukekov | Director | 0 | – | Feb 19, 2025 |
| David A. Rosa | Director | 0 | – | Feb 19, 2025 |
| Patrick F. Williams | Director | 0 | – | Feb 19, 2025 |
| Dale Broadrick | 10% owner | 923,905 | 3.63% | Nov 5, 2024 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Francisco Silva VP of Research and Development, Director | Oct 6, 2025 | Award | +11,719 | $1.60 | $18.75K | 171,384 |
| Lance Alstodt President, CEO, COB, Director, 10% owner | Oct 6, 2025 | Award | +15,625 | $1.60 | $25.00K | 187,497 |
| Dale Broadrick 10% owner | Oct 28, 2024 | Sale | −1,112 | $1.58 | $1.76K | 445,933 |
| Francisco Silva VP of Research and Development, Director | Apr 9, 2024 | Buy | +6,600 | $1.25 | $8.25K | 155,759 |
| Francisco Silva VP of Research and Development, Director | Apr 8, 2024 | Buy | +476 | $1.13 | $538 | 147,927 |
| Francisco Silva VP of Research and Development, Director | Apr 8, 2024 | Buy | +1,232 | $1.17 | $1.44K | 149,159 |
| Lance Alstodt President, CEO, COB, Director | Mar 18, 2024 | Tax withholding | −17,633 | $1.39 | $24.51K | 171,872 |
| Francisco Silva VP of Research and Development, Director | Mar 18, 2024 | Tax withholding | −17,193 | $1.39 | $23.90K | 147,451 |
| Dale Broadrick 10% owner | Feb 9, 2024 | Buy | +86,041 | $1.32 | $113.57K | 477,972 |
| Dale Broadrick 10% owner | Feb 8, 2024 | Buy | +73,959 | $1.25 | $92.45K | 391,931 |
| Dale Broadrick 10% owner | Feb 8, 2024 | Buy | +83,626 | $1.34 | $112.06K | 447,045 |
| Dale Broadrick 10% owner | Feb 7, 2024 | Buy | +36,374 | $1.38 | $50.20K | 363,419 |
| Dale Broadrick 10% owner | Dec 1, 2023 | Sale | −250 | $1.88 | $470 | 327,045 |
| Dale Broadrick 10% owner | Nov 27, 2023 | Sale | −278 | $1.89 | $525 | 327,295 |
| Lance Alstodt President, CEO, COB, Director, 10% owner | Sep 15, 2023 | Buy | +2,200 | $1.70 | $3.74K | 189,505 |
| Dale Broadrick 10% owner | Sep 15, 2023 | Buy | +10,000 | $1.66 | $16.60K | 327,573 |
| Dale Broadrick 10% owner | Sep 14, 2023 | Buy | +10,000 | $1.54 | $15.40K | 317,573 |
| Lance Alstodt President, CEO, COB, Director, 10% owner | Sep 13, 2023 | Buy | +800 | $1.53 | $1.22K | 188,105 |
| Dale Broadrick 10% owner | Sep 7, 2023 | Buy | +1,000 | $1.91 | $1.91K | 317,972 |
| Dale Broadrick 10% owner | Sep 7, 2023 | Buy | +1,000 | $1.81 | $1.81K | 307,573 |
| Lance Alstodt President, CEO, COB, Director, 10% owner | Sep 6, 2023 | Buy | +2,887 | $1.96 | $5.66K | 187,305 |
| Francisco Silva VP of Research and Development, Director, 10% owner | Aug 31, 2023 | Buy | +4,954 | $2.22 | $11.00K | 164,644 |
| Dale Broadrick 10% owner | Jul 28, 2023 | Buy | +500 | $2.89 | $1.45K | 306,573 |
| Dale Broadrick 10% owner | Jul 27, 2023 | Buy | +1,000 | $2.80 | $2.80K | 306,073 |
| Lance Alstodt President, CEO, COB, Director, 10% owner | Jul 25, 2023 | Buy | +4,200 | $2.44 | $10.25K | 184,418 |
| Francisco Silva VP of Research and Development, Director, 10% owner | Mar 31, 2023 | Buy | +747 | $3.56 | $2.66K | 159,690 |
| Lance Alstodt President, CEO, COB, Director, 10% owner | Mar 20, 2023 | Tax withholding | −6,729 | $2.92 | $19.65K | 180,218 |
| Francisco Silva VP of Research and Development, Director, 10% owner | Mar 20, 2023 | Tax withholding | −6,729 | $2.92 | $19.65K | 158,943 |
| Dale Broadrick 10% owner | Feb 22, 2023 | Buy | +5,000 | $2.84 | $14.20K | 304,073 |
| Dale Broadrick 10% owner | Feb 22, 2023 | Buy | +1,000 | $2.95 | $2.95K | 305,073 |
| Francisco Silva VP of Research and Development, Director, 10% owner | Feb 18, 2023 | Tax withholding | −374 | $2.99 | $1.12K | 165,672 |
| Lance Alstodt President, CEO, COB, Director, 10% owner | Feb 18, 2023 | Tax withholding | −374 | $2.99 | $1.12K | 186,947 |
| Lance Alstodt President, CEO, COB, Director | Feb 1, 2023 | Buy | +400 | $3.10 | $1.24K | 187,321 |
| Lance Alstodt President, CEO, COB, Director | Jan 27, 2023 | Buy | +200 | $3.01 | $602 | 186,921 |
| Lance Alstodt President, CEO, COB, Director | Jan 20, 2023 | Buy | +100 | $3.17 | $317 | 186,721 |
| Lance Alstodt President, CEO, COB, Director | Jan 20, 2023 | Buy | +100 | $3.10 | $310 | 186,621 |
| Lance Alstodt President, CEO, COB, Director | Jan 18, 2023 | Buy | +100 | $3.10 | $310 | 186,421 |
| Lance Alstodt President, CEO, COB, Director | Jan 18, 2023 | Buy | +200 | $3.13 | $626 | 186,321 |
| Lance Alstodt President, CEO, COB, Director | Jan 18, 2023 | Buy | +100 | $3.09 | $309 | 186,521 |
| Lance Alstodt President, CEO, COB, Director | Jan 9, 2023 | Buy | +100 | $3.08 | $308 | 186,121 |
| Lance Alstodt President, CEO, COB, Director | Dec 23, 2022 | Buy | +200 | $3.02 | $604 | 185,921 |
| Lance Alstodt President, CEO, COB, Director | Dec 23, 2022 | Buy | +100 | $2.99 | $299 | 186,021 |
| Lance Alstodt President, CEO, COB, Director | Dec 7, 2022 | Buy | +1,800 | $2.99 | $5.38K | 185,721 |
| Dale Broadrick 10% owner | Nov 30, 2022 | Buy | +100 | $2.78 | $278 | 298,973 |
| Dale Broadrick 10% owner | Nov 30, 2022 | Buy | +100 | $2.77 | $277 | 299,073 |
| Francisco Silva VP of Research and Development, Director | Nov 21, 2022 | Buy | +943 | $2.62 | $2.47K | 166,046 |
| Lance Alstodt President, CEO, COB, Director | Nov 18, 2022 | Buy | +1,000 | $2.88 | $2.88K | 183,921 |
| Francisco Silva VP of Research and Development, Director | Oct 12, 2022 | Buy | +725 | $3.39 | $2.46K | 165,103 |
| Francisco Silva VP of Research and Development, Director | Oct 11, 2022 | Buy | +806 | $3.69 | $2.97K | 164,378 |
| Dale Broadrick 10% owner | Sep 23, 2022 | Buy | +300 | $2.83 | $849 | 298,873 |
| Lance Alstodt President, CEO, COB, Director | Sep 22, 2022 | Buy | +100 | $2.85 | $285 | 182,921 |
| Lance Alstodt President, CEO, COB, Director | Sep 22, 2022 | Buy | +100 | $2.99 | $299 | 182,821 |
| Francisco Silva VP of Research and Development, Director | Aug 29, 2022 | Buy | +2,816 | $3.21 | $9.04K | 163,572 |
| Francisco Silva VP of Research and Development, Director | Aug 29, 2022 | Buy | +307 | $3.32 | $1.02K | 12,136 |
| Francisco Silva VP of Research and Development, Director | Aug 26, 2022 | Buy | +2,600 | $3.35 | $8.71K | 160,756 |
| Francisco Silva VP of Research and Development, Director | Aug 26, 2022 | Sale | −3,958 | $3.39 | $13.42K | 158,156 |
| Dale Broadrick 10% owner | Jul 13, 2022 | Buy | +200 | $3.00 | $600 | 298,573 |
| Dale Broadrick 10% owner | Jul 12, 2022 | Buy | +900 | $2.97 | $2.67K | 298,373 |
| Lance Alstodt President, CEO, COB, Director | Jul 12, 2022 | Buy | +700 | $2.95 | $2.07K | 182,721 |
| Dale Broadrick 10% owner | Jul 6, 2022 | Buy | +100 | $3.38 | $338 | 297,473 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.